(Q36644156)

15 August 2017

Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer (English)

1 reference

15 August 2017

1 reference

1 reference

5

P D Siersema

1 reference

15 August 2017

M B Polee

1

1 reference

15 August 2017

F A L M Eskens

2

1 reference

15 August 2017

M E L van der Burg

3

1 reference

15 August 2017

T A W Splinter

4

1 reference

15 August 2017

H W Tilanus

6

1 reference

15 August 2017

J Verweij

7

1 reference

15 August 2017

G Stoter

8

1 reference

15 August 2017

A van der Gaast

9

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

86

1 reference

15 August 2017

5

1 reference

15 August 2017

669-673

1 reference

Chemotherapy in esophageal cancer.

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375296

The changing epidemiology of esophageal cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375296

Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375296

Phase I study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced oesophageal cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375296

Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375296

Chemotherapy with cisplatin and paclitaxel in patients with locally advanced, recurrent or metastatic oesophageal cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375296

A phase II trial of paclitaxel and cisplatin in patients with locally advanced metastatic esophageal cancer: a preliminary report

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375296

A phase II evaluation of high dose cisplatin and etoposide in patients with advanced esophageal adenocarcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375296

Cisplatin and etoposide in oesophageal cancer: a phase II study. Rotterdam Oesophageal Tumour Study Group

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375296

A 15-year review of esophagectomy for carcinoma of the esophagus and cardia.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375296

Neurotoxicity is not enhanced by increased dose intensities of cisplatin administration.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375296

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

30 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6600166

Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy

21 January 2018

1 reference

12 December 2020

A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus

1 reference

12 December 2020

Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus

1 reference

12 December 2020

European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion

1 reference

12 December 2020

Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus

1 reference

12 December 2020

Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer

1 reference

12 December 2020

Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer

1 reference

12 December 2020

Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6600166

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

11875723

1 reference